Warberg Asset Management LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1597506
WINNETKA, IL
Position in ALNY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$301,030
New position
Shares Held
1,000
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#544
of 784 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Warberg Asset Management LLC holds $403,990 across 6 Biotechnology names. ALNY ranks #1 (74.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,000 | $301,030 | |
| 2 | RNTX |
Rein Therapeutics, Inc.
|
99,000 | $102,960 | |
| 3 | BIVI |
Biovie Inc.
|
613,426 | $0 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
94,797 | $0 | |
| 5 | BCTX |
BriaCell Therapeutics Corp.
|
159,555 | $0 | |
| 6 | ERNA |
Ernexa Therapeutics Inc.
|
69,430 | $0 |
All Filings in ALNY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,030 | 1,000 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||